New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
This group comprises agents used for various indications, e.g. hypotension. Respiratory stimulants are classified in R07AB.
Dihydroergotamine, which is used in the treatment of migraine as well as hypotension, is classified in N02CA - Ergot alkaloids.
Combinations with peripheral vasodilators, see C04 - Peripheral vasodilators.
| This group includes various drugs used on different indications. The DDDs are therefore established individually for each substance (i.e. each ATC 5th level). |
C01CA Adrenergic and dopaminergic agents
This group comprises sympathomimetics used in the treatment of hypotension. Centhaquine for the treatment of hypovolemic shock is classified here.
Etilefrine in combination with dihydroergotamine is classified in this group.
Oral products of ephedrine are classified in R03CA.
| ATC code | Name | DDD | U | Adm.R | Note |
| C01CA21 | cafedrine |
Last updated: 2024-01-26